Abstract
Studies of cardiovascular signals continuously sensed by implantable devices provide unique insight into detailed pathophysiology as patients progress from stable to congested states. These data suggest that volume expansion, autonomic adaptation, and pulmonary interstitial edema begin several weeks before patients develop symptoms or demonstrate changes in daily weight. Monitoring physiologic signals from implanted devices may provide earlier warning of impending decompensation, thereby allowing changes in medical therapy to prevent worsening heart failure.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References and Recommended Reading
Hunt SA, Abraham WT, Chin MH, et al.: ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2005, 112:154–235.
Moss AJ, Zareba W, Hall WJ, et al.: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002, 346:877–883.
Bardy GH, Lee KL, Mark DB, et al.: Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005, 352:225–237.
Abraham WT, Fisher WG, Smith AL, et al.: Cardiac resynchronization in chronic heart failure. N Engl J Med 2002, 346:1845–1853.
Bristow MR, Saxon LA, Boehmer J, et al.: Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004, 350:2140–2150.
Cleland JG, Daubert JC, Erdmann E, et al.: The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005, 352:1539–1549.
Piccini JP, Hernandez AF, Dai D, et al.: Use of cardiac resynchronization therapy in patients hospitalized with heart failure. Circulation 2008, 118:926–933.
Levy D, Kenchaiah S, Larson MG, et al.: Long-term trends in the incidence of survival with heart failure. New Engl J Med 2002, 347:1397–1402.
Abraham WT, Schrier RW: Hormones and hemodynamics in heart failure. N Engl J Med 1999, 341:577–585.
Fonarow GC, Abraham WT, Albert NM, et al.: Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZEHF. Arch Intern Med 2008, 168:847–854.
Kimmelstiel C, Levine D, Perry K, et al.: Randomized, controlled evaluation of short and long-term benefits of heart failure disease management within a diverse provider network: The SPAN-CHF trial. Circulation 2004, 110:1450–1455.
Cleland JG, Louis AA, Swedberg K, et al.: Noninvasive home telemonitoring for patients with heart failure at high risk of recurrent admission and death: the Trans European Network-Home-Care Management (TEN-HMS) study. J Am Coll Cardiol 2005, 45:1654–1664.
Hauptman PJ, Rich MW, Heidenreich PA, et al.: The heart failure clinic: a consensus statement of the Heart Failure Society of America. J Card Fail 2008, 14:801–815.
Adamson PB, Magalski A, Braunschweig F, et al.: Ongoing right ventricular hemodynamics in heart failure: clinical value of measurements derived from an implantable monitoring system. J Am Coll Cardiol 2003, 41:565–571.
Magalski A, Adamson PB, Gadler F, et al.: Continuous ambulatory right heart pressure measurements with an implantable hemodynamic monitor: a multicenter, 12-month follow-up study of patients with chronic heart failure. J Card Fail 2002, 8:63–70.
Bourge RC, Abraham WT, Adamson PB, et al.: Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study. J Am Coll Cardiol 2008, 51:1073–1079.
Ritzema J, Melton IC, Richards AM, et al.: Direct left atrial pressure monitoring in ambulatory heart failure patients: initial experience with a new permanent implantable device. Circulation 2007, 116:2952–2959.
McClean D, Aragon J, Jamali A, et al.: Noninvasive calibration of cardiac pressure transducers in patients with heart failure: an aid to implantable hemodynamic monitoring and therapeutic guidance. J Card Fail 2006, 12:568–576.
Verdejo HE, Castro PF, Concepcion R, et al.: Comparison of a radiofrequency-based wireless pressure sensor to Swan-Ganz catheter and echocardiography for ambulatory assessment of pulmonary artery pressure in heart failure. J Am Coll Cardiol 2007, 50:2375–2382.
Castro PF, Concepcion R, Bourge RC, et al.: A wireless pressure sensor for monitoring pulmonary artery pressure in advanced heart failure: initial experience. J Heart Lung Transplant 2007, 26:85–88.
Adamson PB, Conti JB, Smith AL, et al.: Reducing events in patients with chronic heart failure (REDUCEhf) study design: continuous hemodynamic monitoring with an implantable defibrillator. Clin Cardiol 2007, 30:567–575.
Zile M, Bennett TD, St. John Sutton M, et al.: Transition from chronic compensated to acute decompensated heart failure: pathophysiologic insights obtained from continuous monitoring of intracardiac pressures. Circulation 2008, 118:1433–1441.
Zile MR, Bourge RC, Bennett TD, et al.: Application of implantable hemodynamic monitoring in the management of patients with diastolic heart failure: a subgroup analysis of the COMPASS-HF trial. J Card Fail 2008, 14:816–823.
Lewin J, Ledwidge M, O’Loughlin C, et al.: Clinical deterioration in established heart failure: what is the value of BNP and weight gain in aiding diagnosis? Eur J Heart F ail 2005, 7:953–957.
Chaudhry SI, Wang Y, Concato J, et al.: Patterns of weight change preceding hospitalization for heart failure. Circulation 2007, 116:1549–1554.
Adamson PB, Smith AL, Abraham WT, et al.: Continuous autonomic assessment in patients with symptomatic heart failure: prognostic value of heart rate variability measured by an implanted cardiac resynchronization device. Circulation 2004, 110:2389–2394.
Adamson PB, Gilbert EM: Reducing risk of sudden death in heart failure using beta blockers. J Card Fail 2006, 12:734–746.
Adamson PB, Kleckner KJ, VanHout WL, et al.: Cardiac resynchronization therapy improves heart rate variability in patient with symptomatic heart failure. Circulation 2003, 108:266–269.
Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation 1996, 93:1043–1065.
Yu CM, Wang L, Chau E, et al.: Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation 2005, 112:841–848.
Small R, Wickemeyer W, Germany R, et al.: Changes in intrathoracic impedance are associated with subsequent risk of hospitalizations for acute decompensated heart failure: clinical utility of implanted device monitoring without a patient alert. J Card Fail 2009, 15:475–481.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Adamson, P.B. Pathophysiology of the transition from chronic compensated and acute decompensated heart failure: New insights from continuous monitoring devices. Curr Heart Fail Rep 6, 287–292 (2009). https://doi.org/10.1007/s11897-009-0039-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11897-009-0039-z